MAYO CLINIC will collaborate with Kiyatec Inc. on technology platforms for ovarian cancer care. Mayo Clinic is enrolling patients in a study that uses patient-derived xenografts to generate living tumor samples specific to each enrolled ovarian cancer patient. The study assesses whether those samples can help determine which chemotherapy is most effective to treat that...
How’s this for a paradox: The better cancer centers become at keeping patients alive, the more expensive cancer care becomes. This brutal tradeoff hits harder in rural areas, where the cancer burden is higher and the investigator and clinical trial representation is lower.
